Guanbao Zhu

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial

Xiaotian Zhang, Liang Han, Ziyu Li et al. · The Lancet Oncology · 2021 · 440 citations

Medicine, Oncology, Surgery +17

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): final report of a randomised, open-label, phase 3 trial

Xiaotian Zhang, Liang Han, Ziyu Li et al. · The Lancet Oncology · 2025 · 49 citations

Medicine, Oncology, Surgery +16

Hepatitis B virus surface antigen as delivery vector can enhance Chlamydia trachomatis MOMP multi-epitope immune response in mice

Shanli Zhu, Yan Feng, Pinhuan Rao et al. · Applied Microbiology and Biotechnology · 2014 · 37 citations

Life Sciences, Immunology, Infectious Diseases +14

Overexpression of SIRT4 inhibits the proliferation of gastric cancer cells through cell cycle arrest

Yiwang Hu, Jiahao Lin, Yao Lin et al. · Oncology Letters · 2018 · 33 citations · Full text

Life Sciences, Molecular Biology, Oncology +16

Down-regulation of TM4SF is associated with the metastatic potential of gastric carcinoma TM4SF members in gastric carcinoma

Zhouxun Chen, Suchen Gu, Bogusz Trojanowicz et al. · World Journal of Surgical Oncology · 2011 · 28 citations · Full text

Medicine, Oncology, Pathology +16